MARJEANA LAMPSON: Open Payments
NPI 1134887813 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 39 payments from 14 companies in 2025. Trend: 2023 $1,277 · 2024 $1,933 · 2025 $1,093
Food & beverage: $908Education: $185
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $266 |
| Madrigal Pharmaceuticals | 4 | $213 |
| SOBI, INC | 2 | $185 |
| Aimmune Therapeutics, Inc. | 3 | $91 |
| ABBVIE INC. | 3 | $69 |
| Janssen Biotech, Inc. | 3 | $56 |
| Exelixis Inc. | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: REZDIFFRA, OPDIVO, OPDUALAG, VOWST, TREMFYA, MAVYRET, CABOMETYX, KISQALI.
Industry payments across NV — which companies pay providers there.
